Home Newsletters Hematopoiesis News Gilteritinib Enhances Graft-versus-Leukemia Effects against FLT3-ITD Mutant Leukemia after Allogeneic Hematopoietic Stem...

Gilteritinib Enhances Graft-versus-Leukemia Effects against FLT3-ITD Mutant Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

0
Scientists investigated whether gilteritinib, a selective FLT3 inhibitor, could enhance graft-versus-leukemia effects against FLT3 internal tandem duplication mutant transfected Ba/F3 leukemia in mice.
[Bone Marrow Transplantation]
6445212 BBBBBBBB items 1 apa 0 default asc 1 172361 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version